Mount Sinai adopts Flosonics wearable ultrasound device
Flosonics announced today that Mount Sinai Hospital has adopted FloPatch, its wireless Doppler ultrasound device.
Mount Sinai (New York), one of the top hospitals in the U.S., adopted FloPatch in its surgical and transplant intensive care unit (ICU). The company said it marks the company’s first east coast deployment, expanding its U.S. footprint. It also reinforces the growing demand for real-time, individualized fluid management in ICUs.
Sudbury, Ontario-based Flosonics designed FloPatch, an FDA-cleared, non-invasive wearable device, to enable ICU clinicians to perform rapid, repeatable hemodynamic assessments. It guides intravenous (IV) fluid management, a critical intervention in post-surgical care.
